Mary Jo Lamberti, PhD


The Impact of Decentralized and Hybrid Trials on Sponsor and CRO Collaborations

July 27, 2022

Tufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.

Understanding the Complexities of Diversifying Clinical Trials

May 26, 2020

Tufts Center for the Study of Drug Development and Biogen recently conducted a study to inform growing interest in improving diversity of clinical trial participation. The results of this research provide insights into increasing the community of minority investigators and study staff and presenting greater access to clinical trials among minority study volunteers.